These observations indicate that neutrophils, endothelial cells, and epithelial tumor cells in the NSCLC tumor tissues are the major target cells of IL‐36γ and that the crosstalk among the IL‐36γ‐producing cells and IL‐36R‐expression cells critically regulates NSCLC progression. The gene discussed is IL1RL2; the disease is neoplasm.